Abstract
Children with chronic renal failure (CRF) often fail to attain an adult height consistent with their genetic potential. The growth hormone (GH)/insulin-like growth factor (IGF)/growth plate chondrocyte axis has been intensively studied in these children to determine the basis for this growth failure. Evidence suggests that hepatic GH resistance results in deficient expression of IGF-I. However, serum IGF-I levels are usually normal and it is IGF-I action on target tissues which is inhibited, possibly by the presence of excess high-affinity IGF binding proteins (IGFBPs) in CRF serum. In this paper we evaluate the roles of IGFBP-1, -2, and -3 as growth inhibitors in CRF children. The data support a role for each of these IGFBPs as growth inhibitors. Currently, IGFBP-1 meets most criteria expected of a growth inhibitor, but IGFBP-2 and -3 will likely also meet these criteria and may well be important contributors to the growth failure of CRF. Ultimately, many or all of the six IGFBPs may be found to contribute to the excess high-affinity IGF binding sites which are a hallmark of CRF serum and are possible contributors to the growth failure of CRF children.
Similar content being viewed by others
References
Powell DR (1989) Renal disease and growth retardation. Kidney 22: 7–12
Issakson OGP, Lindahl A, Nilsson A, Isgaard J (1987) Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 8: 426–438
Roberts CT, Brown AL, Graham DE, Seelig S, Berry S, Gabbay KH, Rechler MM (1986) Growth hormone regulates the abundance of IGF-1 mRNA in adult rat liver. J Biol Chem 261: 10025–10028
Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM, Russell D (1994) Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats. Endocrinology 135: 1913–1920
Vaccarello MA, Diamond FB, Guevara-Aguirre J, Rosenbloom AL, Fiedler PJ, Gargosky SE, Cohen P, Wilson KF, Rosenfeld RG (1993) Hormonal, metabolic and pharmacokinetic effects of recombinant insulin-like growth factor-I in growth hormone receptor deficient (GHRD) syndrome. J Clin Endocrinol Metab 77: 273–280
El-Bishti M, Counahan R, Bloom S, Chantler C (1978) Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis. Am J Clin Nutr 31: 1865–1869
Powell DR, Rosenfeld RG, Baker BK, Hintz RL (1986) Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor (IGF)-I and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab 63: 1186–1192
Powell DR, Rosenfeld RG, Sperry JB, Baker BK, Hintz RI (1987) Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 10: 287–292
Baxter RC, Martin JL (1989) Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1: 49–68
Lee Y-L, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR (1988) Insulin-like growth factor (IGF) binding protein cDNA from human HEP G2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2: 404–411
Shimasaki S, Shimonaka M, Zhang H-P, Ling N (1991) Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266: 10646–10653
Shimasaki S, Gao L, Shimonaka M, Ling N (1991) Isolation and molecular cloning of insulin-like growth factor binding protein-6. Mol Endocrinol 5: 938–948
Powell DR, Lee PDK, Chang D, Liu F, Hintz RL (1987) Antiserum developed for the E peptide region of insulin-like growth factor-IA prohormone recognizes a serum protein both by immunoblot and by RIA. J Clin Endocrinol Metab 65: 868–875
Liu F, Powell DR, Hintz RL (1990) Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure. J Clin Endocrinol Metab 70: 620–628
Lee PDK, Conover CA, Powell DR (1993) Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 204: 4–29
Brinkman A, Groffen C, Kortleve DJ, Geurts van Kessel A, Drop SLS (1988) Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein. EMBO J 7: 2417–2423
Brown AL, Chiarotti L, Orlowski CC, Mehlman T, Burgess WH, Ackerman EJ, Bruni CB, Rechler MM (1989) Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J Biol Chem 264: 5148–5154
Margot JB, Binkert C, Mary J-L, Landwehr J, Heinrich G, Schwander J (1989) A low molecular weight insulin-like growth factor binding protein from rat: cDNA cloning and tissue distribution of its messenger RNA. Mol Endocrinol 3: 1053–1060
Ooi GT, Orlowski CC, Brown AL, Becker RE, Unterman TG, Rechler MM (1990) Different tissue distribution and hormonal regulation of messenger RNAs endocind rat insulin-like growth factor binding proteins-1 and −2. Mol Endocrinol 4: 321–328
Suwanichkul A, Allander SV, Morris SL, Powell DR (1994) Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein-1 through proximal promoter elements. J Biol Chem 269: 30835–30841
Baxter RC, Martin JL, Beniac VA (1989) High molecular weight insulin-like growth factor binding protein complex. J Biol Chem 264: 11843–11848
Cubbage ML, Suwanichkul A, Powell DR (1990) Insulin-like growth factor binding protein-3 (IGFBP-3): organization of the human chromosomal gene and demonstration of promoter activity. J Biol Chem 265: 12642–12649
Roth RA, Steel-Perkins G, Hari J, Stover C, Pierce S, Turner J, Edman JC, Rutter WJ (1988) Insulin and insulin-like growth factor receptors and responses. Cold Spring Harb Symp Quant Biol 13: 537–543
Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J (1992) Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast. J Biol Chem 267: 12692–12699
Lee PDK, Hintz RL, Sperry JB, Baxter RC, Powell DR (1990) Insulin-like growth factor binding proteins in growth retarded children with chronic renal failure. Pediatr Res 26: 308–315
Baxter RC, Martin JL (1986) Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78: 1504–1512
Blum WF, Ranke MB, Kietzmann K, Tonshoff B, Mehls O (1991) Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 5: 539–544
Blum WF, Horn N, Kratzsch J, Jorgensen JOL, Juul A, Teale D, Mohnike K, Ranke MB (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3: 100–104
Powell DR, Liu F, Baker B, Lee PDK, Belsha CW, Brewer ED, Hintz RL (1993) Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum. Pediatr Res 33: 136–143
Hokken-Koelega ACS, Stijnen T, Muinck Keizer-Schrama SMPF de, Wit JM, Wolff ED, DeJong MCJ, Donckerwolcke RA, Abbad NCB, Bot A, blum WF, Drop SLS (1991) Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338: 585–590
Tonshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Schauer A (1990) Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 116: 561–566
Powell DR, Attie K, Hintz RL, Liu F, Baker BK, Kuntze J, Brown D, Watkins SL, Brewer ED, Hogg RJ (1995) Growth hormone (GH) stimulates growth and alters the serum insulin-like growth factor (IGF) axis of children with chronic renal failure (CRF) — report of the Southwest Pediatric Nephrology Study Group. Pediatric Nephrology 9: C70 (Abstract)
Kale AS, Liu F, Hintz RL, Baker BK, Brewer ED, Lee PDK, Durham SK, Powell DR (1996) Characterization of insulin-like growth factors (IGFs) and IGF binding proteins in peritoneal dialysate. Pediatr Nephrol (in press)
Gargosky SE, Pham HM, Wilson DF, Liu F, Guidice LC, Rosenfeld RG (1992) Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology 131: 3051–3060
Liu F, Hintz RL, Khare A, DiAugustine RP, Powell DR, Lee PDK (1994) Immunoblot studies of the IGF-related acid-labile subunit. J Clin Endocrinol Metab 79: 1883–1886
Fine RN (1991) Growth hormone and the kidney: the use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency. J Am Soc Pediatr Nephrol 1: 1136–1145
Burch WM, Correa J, Shively JE, Powell DR (1990) The 25 kilodalton insulin-like growth factor (IGF) binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro. J Clin Endocrinol Metab 70: 173–180
Binoux M, Hossenlopp P (1988) Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67: 509–514
Knauer DJ, Smith GL (1980) Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. Proc Natl Acad Sci USA 77: 7252–7256
DeMellow JSM, Baxter RC (1988) Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156: 199–204
Conover CA, Ronk M, Lombana F, Powell DR (1990) Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology 127: 2795–2803
Conover CA (1992) Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191–3199
Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P (1995) The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9: 361–367
Martin AA, Tomas FM, Ballard FJ, Read LC (1992) Insulin-like growth factor I and its' variant, des(1–3)IGF-I, improve nitrogen balance and food utilization in rats with renal failure. Miner Electrolyte Metab 18: 264–268
Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR (1991) Phosphorylation of insulin-like growth factor (IGF) binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci USA 88: 7481–7485
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Powell, D.R., Liu, F., Baker, B.K. et al. Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure. Pediatr Nephrol 10, 343–347 (1996). https://doi.org/10.1007/BF00866778
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00866778